​

DaVita (DVA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DVA Stock Forecast

DaVita (DVA) stock forecast, based on 3 Wall Street analysts, predicts a 12-month average price target of $145.00, with a high of $145.00 and a low of $145.00. This represents a -16.56% decline from the last price of $173.77.

$100 $115 $130 $145 $160 $175 High: $145 Avg: $145 Low: $145 Last Closed Price: $173.77

DVA Stock Rating

DaVita stock's rating consensus is Hold, based on 3 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (33.33%), 2 Hold (66.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 3 0 2 1 Strong Sell Sell Hold Buy Strong Buy

DVA Forecast vs Benchmarks

TypeNameUpside
StockDaVita-16.56%
SectorHealthcare Stocks 25.20%
IndustryMedical Care Facilities Stocks19.03%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$147.50
Last Closing Price$173.77$173.77$173.77
Upside/Downside---15.12%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25-17-210
Dec, 24117-211
Nov, 242182215
Oct, 242182215
Sep, 242182114
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 07, 2024Kevin FischbeckBank of America Securities$145.00$133.538.59%-16.56%
May 06, 2024Andrew MokBarclays$150.00$134.4511.57%-13.68%
Oct 31, 2022Sarah JamesBarclays$81.00$70.5414.83%-53.39%
Aug 19, 2022Andrew MokUBS$117.00$93.1025.67%-32.67%
Jun 28, 2022David MacDonaldTruist Financial$90.00$79.4413.29%-48.21%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
May 06, 2024BarclaysEqual-WeightEqual-Weighthold
Jan 05, 2023CFRAHoldupgrade
Aug 19, 2022UBSBuyupgrade
Jun 28, 2022BarclaysEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

$5 $8 $11 $14 $17 $20 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.46$9.30$8.02$7.62-----
Avg Forecast$7.45$8.89$6.21$7.98$9.69$11.41$13.71$15.04$16.96
High Forecast$7.35$8.76$6.15$7.77$9.64$10.75$11.99$13.26$16.81
Low Forecast$7.58$9.04$6.25$8.10$9.76$12.05$15.54$16.82$17.41
Surprise %-13.29%4.61%29.15%-4.51%-----

Revenue Forecast

$11B $12B $13B $14B $15B $16B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$11.55B$11.62B$11.61B$12.14B-----
Avg Forecast$11.57B$11.59B$11.62B$12.01B$12.78B$13.33B$13.79B$14.53B$15.02B
High Forecast$11.44B$11.46B$11.55B$11.98B$12.74B$13.29B$13.78B$14.44B$14.92B
Low Forecast$11.73B$11.74B$11.69B$12.04B$12.83B$13.37B$13.81B$14.61B$15.33B
Surprise %-0.19%0.28%-0.12%1.11%-----

Net Income Forecast

$0 $400M $800M $1B $2B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$773.64M$978.45M$768.19M$691.53M-----
Avg Forecast$603.16M$838.97M$839.66M$691.53M$903.84M$1.06B$1.28B$1.40B$1.58B
High Forecast$482.53M$671.18M$671.73M$553.23M$898.26M$1.00B$1.12B$1.24B$1.57B
Low Forecast$723.79M$1.01B$1.01B$829.84M$909.42M$1.12B$1.45B$1.57B$1.62B
Surprise %28.26%16.63%-8.51%------

DVA Forecast FAQ

Is DaVita stock a buy?

DaVita stock has a consensus rating of Hold, based on 3 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that DaVita is a neutral investment for most analysts.

What is DaVita's price target?

DaVita's price target, set by 3 Wall Street analysts, averages $145 over the next 12 months. The price target range spans from $145 at the low end to $145 at the high end, suggesting a potential -16.56% change from the previous close price of $173.77.

How does DaVita stock forecast compare to the average forecast of its sector, industry, and investment themes?

DaVita stock forecast shows a -16.56% downside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the medical care facilities stocks industry (19.03%).

What is the breakdown of analyst ratings for DaVita over the past three months?

  • January 2025: 0% Strong Buy, 10.00% Buy, 70.00% Hold, 0% Sell, 20.00% Strong Sell.
  • December 2024: 9.09% Strong Buy, 9.09% Buy, 63.64% Hold, 0% Sell, 18.18% Strong Sell.
  • November 2024: 13.33% Strong Buy, 6.67% Buy, 53.33% Hold, 13.33% Sell, 13.33% Strong Sell.

What is DaVita’s EPS forecast?

DaVita's average annual EPS forecast for its fiscal year ending in December is 9.69 for 2024, a 27.17% increase from the reported $7.62 in 2023. The prediction for 2025 is $11.41, $13.71 for 2026, $15.04 for 2027, and $16.96 for 2028.

What is DaVita’s revenue forecast?

DaVita's average annual revenue forecast for its fiscal year ending in December is $12.78B for 2024, a 5.30% increase from the reported $12.14B in 2023. The forecast for 2025 is $13.33B, $13.79B for 2026, $14.52B for 2027, and $15.02B for 2028.

What is DaVita’s net income forecast?

For its fiscal year ending in December, DaVita's average annual net income forecast is $903.84M for 2024, reflecting an 30.70% increase from the reported $691.54M in 2023. The projection for 2025 is $1.06B, $1.28B for 2026, $1.4B for 2027, and $1.58B for 2028.